Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.3.1.900
Income Taxes
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Income Taxes

6. Income taxes

The provision (benefit) for income taxes consists of the following:

 

 

 

Years ended December 31,

 

(amounts in thousands)

 

2015

 

 

2014

 

 

2013

 

Current tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(140

)

 

$

1,139

 

 

$

42

 

State

 

 

102

 

 

 

525

 

 

 

169

 

Total current tax expense (benefit)

 

 

(38

)

 

 

1,664

 

 

 

211

 

Deferred tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

3,639

 

 

 

2,782

 

 

 

798

 

State

 

 

705

 

 

 

3

 

 

 

313

 

Total deferred tax expense

 

 

4,344

 

 

 

2,785

 

 

 

1,111

 

Tax benefit for change in valuation allowance

 

 

(1,164

)

 

 

(1,223

)

 

 

(22,909

)

Total deferred tax expense (benefit), net

 

 

3,180

 

 

 

1,562

 

 

 

(21,798

)

Income tax expense (benefit)

 

$

3,142

 

 

$

3,226

 

 

$

(21,587

)

The components of deferred tax assets and liabilities consist of the following:

 

 

 

As of

 

 

 

December 31,

 

(amounts in thousands)

 

2015

 

 

2014

 

Deferred tax assets (liabilities)

 

 

 

 

 

 

 

 

Accrued expenses

 

$

4,031

 

 

$

3,575

 

Net operating loss and credit carryforward

 

 

11,874

 

 

 

22,924

 

Allowance, reserves and other

 

 

7,509

 

 

 

1,965

 

Deferred tax assets

 

 

23,414

 

 

 

28,464

 

Valuation allowance

 

 

(1,735

)

 

 

(2,899

)

Net deferred tax assets

 

 

21,679

 

 

 

25,565

 

Property, plant, and equipment

 

 

(6,215

)

 

 

(3,674

)

Other

 

 

 

 

 

(1,667

)

Total

 

$

15,464

 

 

$

20,224

 

 

As a result of the realization requirements of ASC 718, the table of deferred tax assets and liabilities does not include certain deferred tax assets as of December 31, 2015 and December 31, 2014, respectively, that arose directly from (or the use of which was postponed by) tax deductions related to equity compensation that are greater than the compensation recognized for financial reporting. Equity will be increased by $12,225 if and when excess tax benefits are ultimately realized. The Company uses ASC 740 ordering when determining when excess tax benefits have been realized.

 

Reconciliation of the federal statutory income tax rate to the effective income tax rate for the last three years is as follows:

 

 

 

Years ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

U.S. Statutory rate

 

 

34.00

%

 

 

34.00

%

 

 

34.00

%

State income taxes, net of federal benefit

 

 

2.00

 

 

 

2.47

 

 

 

5.48

 

Nondeductible expenses

 

 

0.81

 

 

 

1.39

 

 

 

2.54

 

Remeasured deferred for state rate change

 

 

(0.03

)

 

 

(0.25

)

 

 

(8.25

)

Change in valuation allowance

 

 

(7.91

)

 

 

(12.16

)

 

 

(595.34

)

R&D credit, net of reserve

 

 

(2.97

)

 

 

(3.49

)

 

 

 

Expiration of net operating losses

 

 

1.17

 

 

 

8.09

 

 

 

 

Reassessment of prior year APIC benefit

 

 

(3.11

)

 

 

 

 

 

 

Other

 

 

(2.63

)

 

 

2.04

 

 

 

0.58

    

Effective income tax rate

 

 

21.33

%

 

 

32.09

%

 

(560.99

)%

 

The Company is a C-Corporation for both federal and state income tax purposes.

The Company operates in multiple states. The statute of limitations has expired for all tax years prior to 2012 for federal and 2011 to 2012 for various state tax purposes. However, the net operating loss generated on the Company’s federal and state tax returns in prior years may be subject to adjustments by the federal and state tax authorities.

As of December 31, 2015, the Company had $58,434 and $38,991 of federal and state net operating loss carryforwards, respectively, that begin to expire in 2023 and 2016 for federal and state purposes, respectively, if not utilized. As of December 31, 2015, the Company has federal and California research and development credit carryforward of $1,537 and $1,554, respectively. The federal credit will begin to expire in 2022; the California credit has indefinite carryforward.

The Company’s existing net operating losses (NOLs) and credit carryforwards are subject to limitations arising from ownership changes subject to the provisions of Section 382 and 383 of the Internal Revenue Code of 1986, as amended, and if the Company undergoes one or more future ownership changes, the Company’s ability to utilize its NOLs and credit carryforwards could be further limited.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit the use of deferred tax assets. Due to overall cumulative losses incurred over the years, the Company maintained a full valuation allowance against its deferred tax assets as of December 31, 2012. As of December 31, 2013, the Company evaluated the current facts and circumstances and concluded that it was appropriate to release $22,909 of the valuation allowance at December 31, 2013.

As of December 31, 2015 and 2014, the Company was able to determine that, based upon future projections of income, it is more likely than not that all of its federal NOLs will be utilized before they expire. However, the Company determined that some of its California NOLs will expire unused and therefore has a valuation allowance of $1,735 relating to these NOLs as of December 31, 2015. In the current period, the Company released (or reversed) $1,164 of the California NOLs valuation allowance due to expiration of California NOLs and changes in estimates of future projections of income, resulting in a determination that is more likely than not that all but $29,773 ($1,735 tax effected) of the California NOLs will be utilized.

The Company recognizes interest accrued and penalties related to unrecognized tax benefits as income tax expense. No significant interest or penalties were recognized during the periods presented.

Included in the balance of unrecognized tax benefits as of December 31, 2015, 2014 and 2013, are $773, $577 and $306, respectively, of tax benefits that, if recognized, would affect the effective tax rate.

A reconciliation of the beginning and ending amount of unrecognized tax benefit is as follows:

 

 

 

December 31,

 

(amounts in thousands)

 

2015

 

 

2014

 

 

2013

 

Reconciliation of liability for unrecognized tax

   benefits

 

 

 

 

 

 

 

 

 

 

 

 

Balance at beginning of period

 

$

577

 

 

$

306

 

 

$

 

Additions based on tax positions related to current

   year

 

 

176

 

 

 

123

 

 

 

306

 

Additions for tax positions of prior years

 

 

20

 

 

 

148

 

 

 

 

Reductions for tax positions of prior years

 

 

 

 

 

 

 

 

 

Settlements

 

 

 

 

 

 

 

 

 

Balance at end of period

 

$

773

 

 

$

577

 

 

$

306